UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 10-QSB
|X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004
COMMISSION FILE NUMBER 0-29057
|_| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from __________________TO __________________
ALTRIMEGA HEALTH CORPORATION
--------------------------------------------------
(Exact name of registrant as specified in charter)
NEVADA 87-0631750
(State or other jurisdiction of (I.R.S. Employer I.D. No.)
incorporation or organization)
4702 OLEANDER DRIVE, SUITE 200,
MYRTLE BEACH, SC 29577
---------------- -----
(Address of principal executive offices) (Zip)
Issuer's telephone number, including area code (843) 497-7028
Securities registered pursuant to section 12 (b) of the Act:
Title of each class Name of each exchange on which registered
NONE NONE
Securities registered pursuant to section 12 (g) of the Act:
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class)
As of November 15, 2004, the Company had 49,139,950 shares of common stock
issued and outstanding.
Transitional Small Business Disclosure Format (check one).
Yes |_| No |X|
PART I: FINANCIAL INFORMATION
INTRODUCTORY NOTE
FORWARD-LOOKING STATEMENTS
This Form 10-QSB contains "forward-looking statements" relating to
Altrimega Health Corporation ("Altrimega") which represent Altrimega's current
expectations or beliefs including, but not limited to, statements concerning
Altrimega's operations, performance, financial condition and growth. For this
purpose, any statements contained in this Form 10-QSB that are not statements of
historical fact are forward-looking statements. Without limiting the generality
of the foregoing, words such as "may", "anticipation", "intend", "could",
"estimate", or "continue" or the negative or other comparable terminology are
intended to identify forward-looking statements. These statements by their
nature involve substantial risks and uncertainties, such as losses, dependence
on management, variability of quarterly results, and the ability of Altrimega to
continue its growth strategy and competition, certain of which are beyond
Altrimega's control. Should one or more of these risks or uncertainties
materialize or should the underlying assumptions prove incorrect, actual
outcomes and results could differ materially from those indicated in the
forward-looking statements.
Any forward-looking statement speaks only as of the date on which such
statement is made, and the Company undertakes no obligation to update any
forward-looking statement or statements to reflect events or circumstances after
the date on which such statement is made or to reflect the occurrence of
unanticipated events. New factors emerge from time to time and it is not
possible for management to predict all of such factors, nor can it assess the
impact of each such factor on the business or the extent to which any factor, or
combination of factors, may cause actual results to differ materially from those
contained in any forward-looking statements.
2
ITEM 1. FINANCIAL STATEMENTS
ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
CONDENSED CONSOLIDATED BALANCE SHEET
(UNAUDITED)
ASSETS
September 30, 2004
-----------
Current assets
Cash $ 44,640
Accounts receivable 539
Properties held for development or sale 1,500,577
Prepaid expenses 5,600
-----------
Total current assets 1,551,356
Other assets
Accounts receivable - related party 59,560
Deposits 35,000
-----------
Total other assets 94,560
-----------
Total assets $ 1,645,916
===========
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
Notes payable $ 1,539,788
Accounts payable - related parties 263,688
Accounts payable 227,975
-----------
Total current liabilities 2,031,451
-----------
Total liabilities 2,031,451
Commitments and contingencies --
Minority interest (1,191)
Stockholders' deficit
Preferred stock; $0.001 par value; 10,000,000 shares
authorized, 1,000,000 shares issued and outstanding 1,000
Common stock; $0.001 par value; 50,000,000 shares
authorized, 49,139,950 shares issued and outstanding 49,140
Additional paid-in capital 381,560
Accumulated deficit during the development stage (816,044)
-----------
Total stockholders' deficit (384,344)
-----------
Total liabilities and stockholders' deficit $ 1,645,916
===========
See Accompanying Notes to Financial Statements.
3
ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(UNAUDITED)
For the For the For the For the
three months ended three months ended nine months ended nine months ended
September 30, 2004 September 30, 2003 September 30, 2004 September 30, 2003
------------------ ------------------ ------------------ ------------------
Revenue $ 1,065,348 $ 271,679 $ 1,065,348 $ 634,868
Cost of revenue 952,683 260,775 954,312 583,023
------------ ------------ ------------ ------------
Gross profit 112,665 10,904 111,036 51,845
Operating expenses
Consulting and professional fees -- -- -- 69,500
General and administrative 31,291 9,820 86,414 38,954
------------ ------------ ------------ ------------
Total operating expenses 31,291 9,820 86,414 108,454
------------ ------------ ------------ ------------
Loss from operations 81,374 1,084 24,622 (56,609)
Other income (expense)
Interest expense (12,896) (14,444) (32,803) (31,312)
Other income (expense) (2,549) -- 229 --
------------ ------------ ------------ ------------
Total other income (expense) (15,445) (14,444) (32,574) (31,312)
Loss before minority interest 65,929 (13,360) (7,952) (87,921)
Minority interest (16,965) 2,239 (9,007) (1,405)
------------ ------------ ------------ ------------
Loss before provision for income taxes 48,964 (11,121) (16,959) (89,326)
Provision for income taxes -- -- -- --
------------ ------------ ------------ ------------
Net Income (loss) $ 48,964 $ (11,121) $ (16,959) $ (89,326)
============ ============ ============ ============
Basic and diluted loss per common share $ 0.00 $ (0.00) $ (0.00) $ (0.00)
============ ============ ============ ============
Basic and diluted weighted average
common shares outstanding 49,139,950 49,139,950 49,139,950 49,052,038
============ ============ ============ ============
See Accompanying Notes to Financial Statements.
4
ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
For the nine months For the nine months
ended ended
September 30, 2004 September 30, 2003
------------------- --------------------
Net loss $ (16,959) $ (89,326)
Adjustments to reconcile net loss to
net cash used by operating activities:
Minority interest 9,007 1,405
Changes in operating assets and liabilities
Properties held for development or sale (841,062) 439,135
Prepaid commissions -- (4,441)
Accounts receivable - related party 3,000 (57,264)
Accounts receivable (539) --
Accounts payable- related parties 2,777 10,740
Accounts payable 191,889 52,788
--------- ---------
Net cash provided (used) by operating activities (651,887) 353,037
Cash flows from financing activities
Proceeds from notes payable, net of payments 694,788 --
Payments on notes payable -- (398,143)
--------- ---------
Net cash provided (used) by financing activities 694,788 (398,143)
--------- ---------
Net change in cash 42,901 (45,106)
Beginning cash balance 1,739 47,053
--------- ---------
Ending cash balance $ 44,640 $ 1,947
========= =========
Supplemental disclosure of cash flow information:
Cash paid for income taxes $ -- $ --
========= =========
Cash paid for interest $ 32,803 $ 31,312
========= =========
See Accompanying Notes to Financial Statements.
5
ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2004
(UNAUDITED)
1. BASIS OF PRESENTATION
The accompanying unaudited condensed financial statements have been
prepared in accordance with Securities and Exchange Commission
requirements for interim financial statements. Therefore, they do not
include all of the information and footnotes required by accounting
principles generally accepted in the United States for complete financial
statements. The financial statements should be read in conjunction with
the Form 10-KSB for the year ended December 31, 2003 of Altrimega Health
Corporation and Subsidiary. (the "Company").
The interim financial statements present the condensed balance sheet,
statements of operations, stockholders' deficit and cash flows of
Altrimega Health Corporation and Subsidiary. The financial statements have
been prepared in accordance with accounting principles generally accepted
in the United States.
The interim financial information is unaudited. In the opinion of
management, all adjustments necessary to present fairly the financial
position of the Company as of September 30, 2004 and the results of
operations and cash flows presented herein have been included in the
financial statements. Interim results are not necessarily indicative of
results of operations for the full year.
The preparation of financial statements in conformity with accounting
principles generally accepted in the United States requires management to
make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from
those estimates.
Going concern - The accompanying financial statements have been prepared
on a going concern basis, which contemplates the realization of assets and
the satisfaction of liabilities in the normal course of business. The
Company incurred a net loss of approximately $133,000 for the year ended
December 31, 2003, with an accumulated loss from inception of
approximately $799,000. The Company's current liabilities exceed its
current assets by approximately $475,000 as of December 31, 2003. The
Company had a net loss of approximately $17,000 for the nine months ended
September 30, 2004 and an accumulated deficit of approximately $816,000 at
September 30, 2004. The Company's current liabilities exceeded its current
assets by approximately $480,000 at September 30, 2004.
These conditions give rise to substantial doubt about the Company's
ability to continue as a going concern. These financial statements do not
include adjustments relating to the recoverability and classification of
reported asset amounts or the amount and classification of liabilities
that might be necessary should the Company be unable to continue as a
going concern. The Company's continuation as a going concern is dependent
upon its ability to obtain additional financing or sale of its common
stock as may be required and ultimately to attain profitability.
Management's plan, in this regard, is to develop and sale real estate in
order to provide additional working capital for its future planned
activity and to service its debt, which will enable the Company to operate
for the coming year.
6
ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2004
(UNAUDITED)
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Reclassification-Certain prior year balances have been reclassified to conform
to the current year presentation, which have no effect on the loss.
Principles of consolidation - The consolidated financial statements include the
accounts of the Company and its subsidiaries. All significant intercompany
balances and transactions have been eliminated.
Use of estimates - The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of
revenue and expenses during the reporting period. Actual results could differ
from those estimates.
Advertising and marketing costs - The Company recognizes advertising and
marketing costs in accordance with Statement of Position 93-7 "Reporting on
Advertising Costs." Accordingly, the Company expenses the costs of producing
advertisements at the time production occurs, and expenses the costs of
communication advertising in the period in which the advertising space or
airtime is used. Advertising costs are charged to expense as incurred.
Advertising expenses was $6,790 and $- for the year ended December 31, 2003.
Advertising expenses for the three months ended September 30, 2004 was $-0-.
Fair value of financial instruments - The carrying amounts and estimated fair
values of the Company's financial instruments approximate their fair value due
to the short-term nature.
Earnings (loss) per share - Basic earnings (loss) per share excludes any
dilutive effects of options, warrants and convertible securities. Basic earnings
(loss) per share is computed using the weighted-average number of outstanding
common shares during the applicable period. Diluted earnings per share is
computed using the weighted average number of common and common stock equivalent
shares outstanding during the period. Common stock equivalent shares are
excluded from the computation if their effect is antidilutive.
Income taxes - The Company accounts for its income taxes in accordance with
Statement of Financial Accounting Standards No. 109, which requires recognition
of deferred tax assets and liabilities for future tax consequences attributable
to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases and tax credit
carryforwards. Deferred tax assets and liabilities are measured using enacted
tax rates expected to apply to taxable income in the years in which those
temporary differences are expected to be recovered or settled. The effect on
deferred tax assets and liabilities of a change in tax rates is recognized in
income in the period that includes the enactment date.
7
ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2004
(UNAUDITED)
2. SUMMARY OF SIGNIFICANT ACCOUNTINGPOLICIES (CONTINUED)
As of December 31 2003, the Company has available net operating loss carryovers
of approximately $800,000 that will expire in various periods through 2023. Such
losses may not be fully deductible due to the significant amounts of non-cash
service costs. The Company has established a valuation allowance for the full
tax benefit of the operating loss carryovers due to the uncertainty regarding
realization.
Accounting methods - The Company recognizes income and expenses based on the
accrual method of accounting.
Sales of property - Gains from sales of operating properties and revenues from
land sales are recognized using the full accrual method provided that various
criteria relating to the terms of the transactions and any subsequent
involvement by the Company with the properties sold are met. Gains or revenues
relating to transactions which do not meet the established criteria are deferred
and recognized when the criteria are met or using the installment or cost
recovery methods, as appropriate in the circumstances. For land sale
transactions under terms in which the Company is required to perform additional
services and incur significant costs after title has passed, revenues and costs
of sales are recognized proportionately on a percentage of completion basis.
Deposits received prior to closing are recorded as a liability until the
consummation of the sale at which time such amounts are generally applied toward
the purchase price.
Cost of land sales is generally determined as a specific percentage of land
sales revenues recognized for each land development project. The cost
percentages used are based on estimates of development costs and sales revenues
to completion of each project and are revised periodically for changes in
estimates or development plans. The specific identification method is used to
determine cost of sales of certain parcels of land.
Properties - Properties under development are carried at cost reduced for
impairment losses, where appropriate. Properties held for sale are carried at
cost reduced for valuation allowances, where appropriate. Acquisition,
development and construction costs of properties in development and land
development projects are capitalized including, where applicable, salaries and
related costs, real estate taxes, interest and preconstruction costs. The
pre-construction development (or an expansion of an existing property) includes
efforts and related costs to secure land control and zoning, evaluate
feasibility, and complete other initial tasks, which are essential to
development. Provisions are made for potentially unsuccessful preconstruction
efforts by charges to operations.
8
ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2004
(UNAUDITED)
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Properties held for sale are carried at the lower of their carrying values
(i.e., cost less accumulated depreciation and any impairment loss recognized,
where applicable) or estimated fair values less costs to sell. Generally,
revenues and expenses related to property interests acquired with the intention
to resell are not recognized.
Dividend policy - The Company has not adopted a policy regarding payment of
dividends.
Comprehensive loss - The Company has no components of other comprehensive loss.
Accordingly, net loss equals comprehensive loss for all periods.
Segment information - The Company discloses segment information in accordance
with SFAS No. 131, Disclosures about Segments of an Enterprise and Related
Information, which uses the Management approach to determine reportable
segments. The Company operates under one segment.
Employee stock based compensation - The Company applies Accounting Principles
Board ("APB") Opinion No. 25, Accounting for Stock Issued to Employees, and
Related Interpretations, in accounting for stock options issued to employees.
Under APB No. 25, employee compensation cost is recognized when estimated fair
value of the underlying stock on date of the grant exceeds exercise price of the
stock option. For stock options and warrants issued to non-employees, the
Company applies Statement of Financial Accounting Standards ("SFAS") No. 123,
Accounting for Stock-Based Compensation, which requires the recognition of
compensation cost based upon the fair value of stock options at the grant date
using the Black-Scholes option pricing model.
The Company issued no stock and granted no warrants or options to employees for
compensation for the nine months ended September 30, 2004.
In December 2002, the Financial Accounting Standards Board issued SFAS No. 148,
"Accounting for Stock-Based Compensation-Transition and Disclosure". SFAS No.
148 amends the transition and disclosure provisions of SFAS No. 123. The Company
is currently evaluating SFAS No. 148 to determine if it will adopt SFAS No. 123
to account for employee stock options using the fair value method and, if so,
when to begin transition to that method.
Net loss per common share - The Company computes net loss per share in
accordance with SFAS No. 128, Earnings per Share and SEC Staff Accounting
Bulletin No. 98. Under the provisions of SFAS 128 and SAB 98, basic net loss per
share is computed by dividing the net loss available to common stockholders for
the period by the weighted average number of shares of common stock outstanding
during the period. The calculation of diluted net loss per share gives effect to
common stock equivalents, however, potential common shares are excluded if their
effect is antidilutive. For the three months ended September 30, 2004, for the
year ended December 31, 2003 and the period from July 3, 2002 (Inception)
through December 31, 2003, no shares were excluded from the computation of
diluted earnings per share because their effect would be antidilutive.
New accounting pronouncements - In July 2001, the FASB issued SFAS No. 143,
Accounting for Obligations Associated with the Retirement of Long-Lived Assets.
SFAS No. 143 establishes accounting standards for the recognition and
measurement of an asset retirement obligation and its associated asset cost. Its
retirement also provides accounting guidance for legal obligations associated
with the retirement of tangible long-lived assets. SFAS No. 143 is effective in
fiscal years beginning after June 15, 2002, with early adoption permitted. The
adoption of SFAS No. 143 did not have a material impact on the Company's
financial statements.
9
ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2004
(UNAUDITED)
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
In August 2001, the FASB issued SFAS No. 144, Accounting for the Impairment or
Disposal of Long-Lived Assets. SFAS 144 establishes a single accounting model
for the impairment or disposal of long-lived assets, including discontinued
operations. SFAS 144 superseded Statement of Financial Accounting Standards No.
121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived
Assets to Be Disposed Of, and APB Opinion No. 30, Reporting the Results of
Operations - Reporting the Effects of Disposal of a Segment of a Business, and
Extraordinary, Unusual and Infrequently Occurring Events and Transactions. The
provisions of SFAS No. 144 are effective in fiscal years beginning after
December 15, 2001, with early adoption permitted, and in general are to be
applied prospectively. The adoption of SFAS No. 144 did not have a material
impact on the Company's financial statements for the three months ended
September 30, 2004 or the years ended December 31, 2003 and 2002.
In July 2002, the FASB issued Statement No. 146, Accounting for Costs Associated
with Exit or Disposal Activities. SFAS No. 146 addresses financial accounting
and reporting for costs associated with exit or disposal activities, such as
restructurings, involuntarily terminating employees, and consolidating
facilities initiated after December 31, 2002. The implementation of SFAS No. 146
did not have a material effect on the Company's financial statements for the
three months ended September 30, 2004 or the years ended December 31, 2003 and
2002.
In April 2003, the FASB issued SFAS No. 149, Amendment of SFAS No. 133,
Accounting for Derivative Instruments and Hedging Activities. SFAS No. 149
amends SFAS No. 133 for decisions made (1) as part of the Derivatives
Implementation Group process that effectively required amendments to SFAS No.
133, (2) in connection with other Board projects dealing with financial
instruments, and (3) in connection with implementation issues raised in relation
to the application of the definition of a derivative. The Statement clarifies
under what circumstances a contract with an initial net investment meets the
characteristics of a derivative discussed in paragraph 6(b) of SFAS No. 133,
clarifies when a derivative contains a financing component, amends the
definition of underlying to conform it to language used in FASB Interpretation
No. 45, Guarantor's Accounting and Disclosure Requirements for Guarantees,
Including Indirect Guarantees of Indebtedness of Others, and amends certain
other existing pronouncements. Those changes will result in more consistent
reporting of contracts as either derivatives or hybrid instruments. This
statement is effective for contracts entered into or modified after June 30,
2003 and for hedging relationships designated after June 30, 2003. The
implementation of SFAS No. 149 did not have a material on the Company's
financial statements.
In May 2003, the FASB issued SFAS No. 150, Accounting for Certain Financial
Instruments with Characteristics of Both Liabilities and Equity. SFAS No. 150
establishes standards for how an issuer classifies and measures certain
financial instruments with characteristics of both liabilities and equity. In
addition, the Statement requires an issuer to classify certain instruments with
specific characteristics described in it as liabilities. This Statement is
effective for financial instruments entered into or modified after May 31, 2003,
and otherwise is effective at the beginning of the first interim period
beginning after June 15, 2003. The implementation of SFAS No. 150 is not
expected to have a material effect on the Company's financial statements.
10
ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2004
(UNAUDITED)
3. BUSINESS COMBINATIONS AND ACQUISITIONS
Sea Garden Funding, LLC - In November 2001, the Company acquired 80% of Sea
Garden Funding, LLC (a South Carolina Limited Liability Company) in exchange for
the assumption of certain liabilities. The Company will account for its 80%
ownership interest in Sea Garden Funding, LLC using the purchase method of
accounting under APB No. 16. The results of operations for the acquired company
have been included in the consolidated financial results of the Company from the
date of such transaction forward. The Company acquired the project from Sea
Garden, LLC on October 21, 2002 for the payment of $210,000 and the assumption
of $1,071,344.66 in mortgages on the real property held by Horry County State
Bank. The remaining 20% interest in Sea Garden Funding, LLC, is owned by an
unaffiliated party, Tom Roe, an individual, of Myrtle Beach, South Carolina. The
acquisition was made by exercising an option that Creative Holdings, Inc., held
on the parcel. The option was not valued as no consideration was given by
Creative Holdings to hold the option. The real property held by Sea Garden, LLC
was acquired prior to Creative's acquisition of Sea Garden Funding, LLC.
In accordance with APB No. 16, all identifiable assets were assigned a portion
of the cost of the acquired company (purchase price) on the basis of their
respective fair values. Intangible assets were identified and valued by
considering the Company's intended use of the acquired assets and analysis of
data concerning products, technologies, markets, historical performance, and
underlying assumptions of future performance. The economic environments in which
the Company and the acquired company operate were also considered in the
valuation analysis.
4. NOTES PAYABLE
Notes payable consists of the following as of September 30,
2004:
Promissory note payable secured by real estate, payable in
monthly installments of interest only at 6.0%, due March 2005 $ 70,000
Promissory note payable secured by real estate, payable in
quarterly installments of interest only at prime lending
rate plus 0.5% (4.75% as of September 30, 2004), due
December 2004 200,000
Promissory note payable with ability to draw up to $360,000
secured by real estate, payable in monthly installments of
interest only at prime lending rate plus 0.5% (4.75% as of
September 30, 2004), due December 2004 3,773
Promissory note payable with ability to draw up to $365,000
secured by real estate, payable in monthly installments of
interest only at prime lending rate plus 0.5% (4.75% as of
September 30, 2004), due December 2004 91,011
Promissory note payable with ability to draw up to $760,000
secured by real estate, payable in monthly installments of
interest only at prime lending rate plus 0.5% (4.75% as of
September 30, 2004), due December 2004 505,560
Promissory note payable with ability to draw up to $640,000
secured by real estate, payable in monthly installments of
interest only at prime lending rate plus 0.5% (4.75% as of
September 30, 2004), due September 2005 304,803
Promissory note payable with ability to draw up to $690,000
secured by real estate, payable in monthly installments of
interest only at prime lending rate plus 0.5% (4.75% as of
September 30, 2004), due July 2005 364,641
----------
1,539,788
Less amounts due within one year: 1,539,788
----------
Long-term portion of loan payable $ --
==========
11
5. RELATED PARTY TRANSACTIONS
Accounts receivable - related party - As of September 30, 2004, the Company has
made a non-interest bearing, due on demand loan to the minority interest holder
of Sea Garden Funding, LLC, which as of September 30, 2004 totaled $59,560.
Accounts payable - related parties - As of September 30, 2004,
officers-directors, and their controlled entities, have acquired 36% of the
outstanding stock of the Company, after the conversion of the preferred shares
to common shares, and have made non-interest bearing, due on demand loans to the
Company totaling $263,688.
Executive employment agreement - During 2003 the Company entered into an
employment agreement with an officer, which provides for an annual salary of
$100,000 with a 5% increase each year to a maximum of $125,000, provided the
Company has a profit in the previous year.
6. STOCKHOLDERS' DEFICIT
During 2002, the Company issued 10,500,000 shares of common stock at a weighted
average fair value of approximately $0.03 per share for services.
During 2002, the Company issued 18,499,700 shares of the Company's common stock
in consideration of the AHC Transaction, as discussed in Note 1. A recipient of
approximately 5,000,000 shares of the common stock returned 4,879,750 shares to
the Company which were cancelled accordingly.
During the first quarter of 2003, the Company issued 3,000,000 shares of common
stock in satisfaction of accounts payable of $79,500 (including interest of
$39,500).
7. COMMITMENTS AND CONTINGENCIES
Leased facility - The Company paid $600 per month to lease a townhouse unit for
its model on a non-cancelable lease which expired in April 2004. The owner of
the unit agreed to a three-month extension of the lease for $2,400. The lease
agreement is currently expires and the Company no longer leases this unit.
The Company has a consulting agreement, with unrelated parties, which provides
for a quarterly payment of $45,000.
8. SUBSEQUENT EVENTS
During October 2004, the Company signed a non-binding Letter of Intent to
acquire all of the outstanding shares of common stock of Top Gun Sports &
Entertainment, Inc., in exchange for the issuance of 26,000,000 shares of the
Altrimega Health Corporation common stock to the current shareholders of Top Gun
Sports & Entertainment, Inc. Altrimega Health would effect a 1-for-1000 reverse
stock split prior to closing the proposed merger. This acquisition is
conditioned upon Altrimega Health increasing its authorized shares of common
stock to 250,000,000, obtaining specified financing and obtaining approval of a
majority of its shareholders.
12
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
PLAN OF OPERATION
GENERAL
The following discussion and analysis should be read in conjunction with
the Condensed Consolidated Financial Statements, and the Notes thereto included
herein. The information contained below includes statements of Altrimega's or
management's beliefs, expectations, hopes, goals and plans that, if not
historical, are forward-looking statements subject to certain risks and
uncertainties that could cause actual results to differ materially from those
anticipated in the forward-looking statements. For a discussion on
forward-looking statements, see the information set forth in the Introductory
Note to this Annual Report under the caption "Forward Looking Statements", which
information is incorporated herein by reference.
GOING CONCERN
As reflected in Altrimega's financial statements for the three months
ended September 30, 2004, Altrimega's accumulated deficit of $816,044 and its
working capital deficiency of $480,095 raise substantial doubt about its ability
to continue as a going concern. The ability of Altrimega to continue as a going
concern is dependent on Altrimega's ability to raise additional debt or capital.
The financial statements for September 30, 2004 do not include any adjustments
that might be necessary if Altrimega is unable to continue as a going concern.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Management's discussion and analysis of our financial condition and
results of operations are based upon our consolidated financial statements,
which have been prepared in accordance with accounting principles generally
accepted in the United States of America. The preparation of these financial
statements requires that we make estimates and judgments that affect the
reported amounts of assets, liabilities, revenues and expenses. At each balance
sheet date, management evaluates its estimates. We base our estimates on
historical experience and on various other assumptions that are believed to be
reasonable under the circumstances. Actual results may differ from these
estimates under different assumptions or conditions. The estimates and critical
accounting policies that are most important in fully understanding and
evaluating our financial condition and results of operations include those
listed below.
REVENUE RECOGNITION
Gains from sales of operating properties and revenues from land sales are
recognized using the full accrual method provided that various criteria relating
to the terms of the transactions and any subsequent involvement by the Company
with the properties sold are met. Gains or revenues relating to transactions
which do not meet the established criteria are deferred and recognized when the
criteria are met or using the installment or cost recovery methods, as
appropriate in the circumstances. For land sale transactions under terms in
which the Company is required to perform additional services and incur
significant costs after title has passed, revenues and costs of sales are
recognized proportionately on a percentage of completion basis. Deposits
received prior to closing are recorded as a liability until the consummation of
the sale at which time such amounts are generally applied toward the purchase
price.
Cost of land sales is generally determined as a specific percentage of
land sales revenues recognized for each land development project. The cost
percentages used are based on estimates of development costs and sales revenues
to completion of each project and are revised periodically for changes in
estimates or development plans. The specific identification method is used to
determine cost of sales of certain parcels of land.
PROPERTIES
Properties under development are carried at cost reduced for impairment
losses, where appropriate. Properties held for sale are carried at cost reduced
for valuation allowances, where appropriate. Acquisition, development and
construction costs of properties in development and land development projects
are capitalized including, where applicable, salaries and related costs, real
estate taxes, interest and preconstruction costs. The pre-construction
development (or an expansion of an existing property) includes efforts and
related costs to secure land control and zoning, evaluate feasibility, and
complete other initial tasks, which are essential to development. Provisions are
made for potentially unsuccessful preconstruction efforts by charges to
operations.
13
Properties held for sale are carried at the lower of their carrying values
(i.e., cost less accumulated depreciation and any impairment loss recognized,
where applicable) or estimated fair values less costs to sell. Generally,
revenues and expenses related to property interests acquired with the intention
to resell are not recognized.
Stock-based compensation - The Company applies Accounting Principles Board
("APB") Opinion No. 25, Accounting for Stock Issued to Employees, and Related
Interpretations, in accounting for stock options issued to employees. Under APB
No. 25, employee compensation cost is recognized when estimated fair value of
the underlying stock on date of the grant exceeds exercise price of the stock
option. For stock options and warrants issued to non-employees, the Company
applies SFAS No. 123, Accounting for Stock-Based Compensation, which requires
the recognition of compensation cost based upon the fair value of stock options
at the grant date using the Black-Scholes option pricing model.
PRINCIPALS OF CONSOLIDATION
The consolidated financial statements shown in this report excludes the
historical operating information of the parent before September 30, 2002, and
includes the operating information of the subsidiary, Creative Holdings, Inc.,
from July 3, 2002 (date of inception of the subsidiary), and the operating
information of Sea Garden Funding, LLC from November 2002 (the date of the
purchase of 80% of the LLC) to December 31, 2003.
All intercompany transactions have been eliminated.
RESTATEMENT OF FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2002
Subsequent to the issuance of the Company's financial statements,
management became aware that those financial statements did not reflect account
balances properly for the period from July 3, 2002 (date of inception) through
December 31, 2002. Properly accounting of these items in the revised financial
statements has the following effect:
For the period from July 3, 2002 (date of inception) through December 31,
2002, the change in the statement of operations primarily related to the
accounting for the share exchange agreement between Altrimega and Creative
Holdings, which was not properly reported as a transaction identical to that
resulting from a reverse acquisition, except goodwill or other intangible assets
are not recorded. The net change of $171,756 increased the net loss from
$494,507 ($0.01 per weighted average common share outstanding) to $666,263
($0.06 per weighted average common share outstanding) for the period from July
3, 2002 (date of inception) through December 31, 2002. The Company has filed an
amendment to its Form 10-KSB for fiscal year ended December 31, 2002, as well as
amendments to its quarterly reports for fiscal year 2003.
RESULTS OF OPERATIONS FOR THE THREE MONTH PERIOD ENDED SEPTEMBER 30, 2004,
COMPARED TO THE THREE MONTH PERIOD ENDED SEPTEMBER 30, 2003
REVENUES
Revenue for the three month period ended September 30, 2004, was
$1,065,348, an increase of $793,669, as compared to $271,679 in revenues for the
same period ended September 30, 2003. The increase in revenues in 2004 was
attributable to the sales of nine units at the Sea Garden project in the third
quarter, where the Company sold 2 units in 2003. We anticipate revenues for the
fiscal year ending 2004 to consist mainly or completely of the sale of units at
the Sea Garden Project.
COST OF REVENUE. There was $952,683 cost of revenue for the three month
period ended September 30, 2004, compared to $260,775 in the September 30, 2003
period. The difference is attributable to the additional unit sales in 2004
compared to unit sales in 2003.
GROSS PROFIT. Gross profit for the three month period ended September
30, 2004 was $112,665 due to increase unit sales at the Sea Garden project. The
gross profit for the three months ended September 30,2003 was $10,904.
OPERATING EXPENSES. Operating expenses for the three month period ended
September 30, 2004, were $31,291, as compared to $9,820, for the three period
ended September 30, 2003. Operating expenses in 2004 consisted of $31,291 in
general and administrative expenses. The increase of $21,471 from 2003 to 2004
was attributable to an increase in legal and accounting costs related to
restating the Company's financial reports for past periods.
14
OTHER INCOME (EXPENSE). Other income (expense) for the three month period
ended September 30, 2004, was a net expense of $15,445, an increase of $1,011,
as compared to a net expense of $14,444 for the three month period ended
September 30, 2003. The expense in the 2004 period consisted mainly of $12,896
in interest expense.
NET INCOME (LOSS). Altrimega had a net income of $48,964 for the three
month period ended September 30, 2004, as compared to a net loss of ($11,121)
for the period ended September 30, 2003. The difference of $60,085 was
attributable to increased unit sales at the Sea Garden project.
RESULTS OF OPERATIONS FOR THE NINE MONTH PERIOD ENDED SEPTEMBER 30, 2004,
COMPARED TO THE NINE MONTH PERIOD ENDED SEPTEMBER 30, 2003
REVENUES
Revenue for the nine month period ended September 30, 2004, was
$1,065,348, an increase of $430,480, as compared to $634,868 in revenues for the
nine month period ended September 30, 2003. The increase in revenues in 2004 was
attributable to the sales of nine units at the Sea Garden project in 2004. We
anticipate revenues for the fiscal year ending 2004 to consist mainly or
completely of the sale of units at the Sea Garden Project.
COST OF REVENUE
There was $954,312 cost of revenue for the nine month period ended
September 30, 2004, compared to $583,023 in the September 30, 2003 nine month
period. The difference is attributable to additional unit sales in 2004 compared
to unit sales in 2003.
GROSS PROFIT
Gross profit for the nine month period ended September 30, 2004 was
$111,306. The gross profit relates to the sale of units at the Sea Garden
project. The gross profit for the nine month period ended September 30, 2003 was
$51,845.
OPERATING EXPENSES
Operating expenses for the nine month period ended September 30, 2004,
were $86,414, as compared to $108,454, for the nine month period ended September
30, 2003. Operating expenses in 2004 consisted of $86,414 in general and
administrative expenses. The decrease of $22,040 from 2004 to 2003 was
attributable to a decrease in consulting and professional fees, which equaled
$69,500 in the nine month period ended September 30, 2003.
OTHER INCOME (EXPENSE)
Other income (expense) for the nine month period ended September 30, 2004,
was a net expense of $32,574, as compared to a net expense of $31,312 for the
nine month period ended September 30, 2003. Other expense in 2004 and 2003 was
primarily attributable to interest expense from loans used in the construction
of buildings at Sea Gardens and the two mortgages on the remaining land at the
Sea Garden project.
NET LOSS Altrimega had a net loss of $16,959 for the nine month period
ended September 30, 2004, as compared to a net loss of $89,326 for the nine
month period ended September 30, 2003. The decrease of $72,367 was mostly
attributable to a combination of decreased consulting fees and additional unit
sales in the Sea Garden project in the September 30, 2004 nine month period.
LIQUIDITY AND CAPITAL RESOURCES
Altrimega's financial statements have been prepared on a going concern
basis that contemplates the realization of assets and the settlement of
liabilities and commitments in the normal course of business. Altrimega incurred
a net loss of $16,959 and $89,326 for the nine month periods ended September 30,
2004 and September 30, 2003, respectively, and has an accumulated deficit of
$816,044 at September 30, 2004. As of September 30, 2004, we had total assets of
$1,645,916 and total liabilities of $2,031,451, a difference of $385,535.
Additionally, our current assets were $1,551,356 and our current liabilities
were $2,031,451, creating a working capital deficit of $480,095. The majority of
the assets, $1,500,557 consist of building sites contained within the Sea Garden
town home community.
15
Consequently, the majority of our liabilities, $1,539,788 are mortgage
loans on the Sea Garden assets. Accounts payable to related parties equal to
$263,688 are also included in our liabilities. Management recognizes that
Altrimega must generate or obtain additional capital to enable it to continue
operations. Management is planning to obtain additional capital principally
through the sale of equity securities. The realization of assets and
satisfaction of liabilities in the normal course of business is dependent upon
Altrimega obtaining additional equity capital and ultimately obtaining
profitable operations. However, no assurances can be given that Altrimega will
be successful in these activities. Should any of these events not occur, the
accompanying consolidated financial statements will be materially affected.
We had limited operations and revenues during the nine month period ended
September 30, 2004. Our shortfall in working capital has been met through
advances from our president, John Gandy, and other shareholders who have
advanced funds to pay expenses incurred by the Company from time to time. At no
time during the period did these short term loans exceed $50,000.
For the nine months ended September 30, 2004, the Company used net cash in
operations of $651,887, no cash for investing activities and had $694,788 in
cash provided by financing activities as a result of proceeds from notes
payable.
We anticipate that we will require significant capital to maintain our
corporate viability and execute our plan to develop real estate projects. We
anticipate necessary funds will most likely be provided by our existing
shareholders, our officers and directors, and outside investors. We will require
significant loan guarantees to acquire properties for development and to
complete construction on any additional construction projects. We may be
required to pledge equity in the Company to induce individuals, officers or
directors or other shareholders to guarantee our loans when necessary.
Altrimega is at present meeting its current obligations from its monthly
cash flows, which during 2003, and to date in 2004 has included cash from
operations, investor capital, and loans from related parties. However, due to
insufficient cash generated from operations, Altrimega currently does not have
internally generated cash sufficient to pay all of its incurred expenses and
other liabilities. As a result, Altrimega is dependent on investor capital and
loans to meet its expenses and obligations. Although related party loans have
allowed Altrimega to meet its obligations in the recent past, there can be no
assurances that Altrimega's present methods of generating cash flow will be
sufficient to meet future obligations. There can be no assurances that Altrimega
will be able to raise sufficient additional capital in the future.
We have incurred losses since inception. Management believes that it will
require approximately $50,000 in additional capital to fund overall Company
operations for the next twelve months. This amount does not include monies
necessary to construct new townhouse units at Sea Garden. Altrimega currently
has approximately $44,640 in cash and cash equivalents as of September 30, 2004.
PLAN OF OPERATION
The Company derives it revenue from the sale of developed or undeveloped
real estate parcels. At present, the Company has one project generating
revenues, Sea Garden Town Homes, located in North Myrtle Beach, South Carolina
These Town Homes sell in the $95,000 to $105,000 range per Town Home unit. The
Company owns the building sites for an additional 49 units and is under
construction on all remaining units. These units have been pre-sold and all
sales and construction are set to be completed by January 30, 2005.
It is important for the Company to raise capital funds through the sell of
its common stock in order to provide funding for additional projects. The
projected revenues and subsequent net earnings from the Sea Garden project are
not adequate to cover the Company's annual operating costs on an ongoing basis.
Altrimega intends to strive to locate, evaluate and proceed to finance and
develop multiple projects located primarily in the Myrtle Beach, South Carolina
area and the Carolinas area of the United States. Management believes that these
areas provide the population growth necessary to achieve profits from new
construction projects. For the last three years, Horry County, South Carolina
has been one of the top three fastest growing counties in the United States. In
1997, Horry County showed a population of only 180,000. Based on current
projections and the 2000 census data, the county will have a permanent
population of 500,000. The principal industries of the area are tourism related.
Myrtle Beach is considered a drive-in market, where tourists will drive their
cars rather than fly to the destination. The tourism industry in Myrtle Beach
has developed three seasons, spring golf, summer beach vacations and fall golf.
The spring and fall golf seasons bring approximately 150,000 visitors per week
to play on the areas over 100 golf courses. The summer vacation season brings in
approximately 400,000 per week. The average tourist stay is one week.
16
Altrimega's business strategy includes a focus on interval ownership
properties, also known as time-share properties, that cater to this major
tourism industry. As well, we intend to develop projects in the medium price
ranges for the areas permanent service industry population.
Management intends to attempt to seek out low-risk projects that do not
require large financing commitments. In addition, we will continue to evaluate
projects throughout the Carolinas in high growth areas.
Our continuation as a going concern is dependent on our ability to meet
our obligations and obtain additional debt or equity financing required until
our current and proposed real estate projects are under way and generating
earnings. Until such time as these projects are generating earnings, we have
taken the following steps to revise our operating and financial requirements in
an effort to enable us to continue in existence:
o We have reduced administrative expenses to a minimum by
consolidating management responsibilities to our president and chief
executive officer.
o We intend to seek either equity or further debt funding.
o We intend to attempt to obtain the professional services of
third-parties through favorable financing arrangements or payment by
the issuance of our common stock.
We believe that the foregoing plan should enable us to generate sufficient
funds to continue its operations for the next twelve months.
Management has implemented this plan to attempt to overcome the Company's
serious going concern conditions. The first step is to reduce operating costs.
To this end the Company's President and Chief Executive Officer, John Gandy, has
assumed almost all of the Company's functions from sales and marketing, locating
and evaluating new real estate projects, most accounting functions, shareholder
relations and general administrative functions. Mr. Gandy has foregone any
compensation for the last half of 2003, and has committed to continue with no
compensation through at least the first six months of 2004. Mr. Gandy continues
to receive no compensation. The Company's Chief Financial Officer is receiving
no compensation. The Company anticipates reduced consulting expense in the next
fiscal year. Only one consultant is on hand for additional help in evaluating
projects and working with the accounting and reporting functions of the Company.
Administrative expenses, including mostly legal and accounting charges, will
constitute the largest expense items for the year. The Company has made
arrangements with these outside professionals to work more efficiently with them
to help reduce the overall costs associated with these services.
In addition, the Company has located some potential sources of equity
financing that could contribute to the Company's financial requirements in the
upcoming fiscal year. This element is especially critical to the Company's going
concern situation. Before these sources can be fully explored, the Company must
completely prior comments from the Securities and Exchange Commission concerning
some of Altrimega's prior filings. Management is in the process of correcting
this filing.
For the next 12 months we anticipate that we will need $150,000 to
continue to fund basic operations, in addition to funding necessary to acquire
and develop real estate projects. The Company anticipates approximately $180,000
in consulting fees in the next fiscal year and only minor operating expenses.
Any new real estate projects will require debt financing. In summary, we expect
expenses to decline in the coming fiscal year due to a decrease in consulting
fees and no other increases in operating expenses.
The Company plans to continue operating with small administrative and
consulting fees in the next fiscal year in order to continue operations.
Continuing to work with its accounting and legal professionals more efficiently,
the Company plans to reduce its fees for such services. In addition, the Company
plans to utilize only one consultant for accounting services.
From time to time, Altrimega may evaluate potential acquisitions involving
complementary businesses, content, products or technologies. Altrimega has no
present agreements or understanding with respect to any such acquisition.
Altrimega's future capital requirements will depend on many factors, including
an increase in Altrimega's real estate projects, and other factors including the
results of future operations.
17
ITEM 3. CONTROLS AND PROCEDURES
(A) EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES
As of the end of the period covered by this report, the Company carried
out an evaluation, under the supervision and with the participation of the
Company's Principal Executive Officer and Principal Financial Officer of the
effectiveness of the design and operation of the Company's disclosure controls
and procedures. The Company's disclosure controls and procedures are designed to
provide a reasonable level of assurance of achieving the Company's disclosure
control objectives. The Company's Principal Executive Officer and Principal
Accounting Officer have concluded that the Company's disclosure controls and
procedures are, in fact, effective at this reasonable assurance level as of the
period covered.
(B) CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING
In connection with the evaluation of the Company's internal controls
during the Company's quarter ended September 30, 2004, the Company's Principal
Executive Officer and Principal Financial Officer have determined that there are
no changes to the Company's internal controls over financial reporting that has
materially affected, or is reasonably likely to materially effect, the Company's
internal controls over financial reporting.
18
PART II
OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None.
ITEM 2. CHANGES IN SECURITIES
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. SUBMISSION OF MATTERS TO BE A VOTE OF SECURITY HOLDERS
None
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(A) EXHIBITS:
EXHIBIT
NUMBER TITLE OF DOCUMENT LOCATION
------ ----------------- --------
31.1 Certification by Chief Executive Officer Provided herewith
pursuant to 15 U.S.C. Section 7241, as adopted
pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
31.2 Certification by Chief Financial Officer Provided herewith
pursuant to 15 U.S.C. Section 7241, as adopted
pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
32.1 Certification by Chief Executive Officer Provided herewith
pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002
19
(B) REPORTS ON FORM 8-K:
On October 8, 2004, Altrimega Health Corporation, d/b/a Creative Holdings
& Marketing Corporation signed a non-binding Letter of Intent to acquire all of
the outstanding shares of common stock of Top Gun Sports & Entertainment, Inc.,
in exchange for the issuance of 26,000,000 shares of the Altrimega Health
Corporation common stock to the current shareholders of Top Gun Sports &
Entertainment, Inc. Altrimega Health would effect a 1-for-1000 reverse stock
split prior to closing the proposed merger. This acquisition is conditioned upon
Altrimega Health increasing its authorized shares of common stock to
250,000,000, obtaining specified financing and obtaining approval of a majority
of its shareholders.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Company has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
NOVEMBER 15, 2004 ALTRIMEGA HEALTH CORPORATION
By: /s/ John Gandy
---------------------------
John Gandy,
Chief Executive Officer and
Director
By: /s/ Ron Hendrix
---------------------------
Ron Hendrix,
Chief Financial Officer and
Secretary
20